Par Sui, Vaides Sofia, VanderVere-Carozza Pamela S, Pawelczak Katherine S, Stewart Jason, Turchi John J
Indiana University Comprehensive Cancer Center, Indiana University School of Medicine, Indianapolis, IN 46202, USA.
Department of Medicine, Indiana University School of Medicine, Indianapolis, IN 46202, USA.
Cancers (Basel). 2021 Jul 3;13(13):3346. doi: 10.3390/cancers13133346.
Genome stability and maintenance pathways along with their requisite proteins are critical for the accurate duplication of genetic material, mutation avoidance, and suppression of human diseases including cancer. Many of these proteins participate in these pathways by binding directly to DNA, and a subset employ oligonucleotide/oligosaccharide binding folds (OB-fold) to facilitate the protein-DNA interactions. OB-fold motifs allow for sequence independent binding to single-stranded DNA (ssDNA) and can serve to position specific proteins at specific DNA structures and then, via protein-protein interaction motifs, assemble the machinery to catalyze the replication, repair, or recombination of DNA. This review provides an overview of the OB-fold structural organization of some of the most relevant OB-fold containing proteins for oncology and drug discovery. We discuss their individual roles in DNA metabolism, progress toward drugging these motifs and their utility as potential cancer therapeutics. While protein-DNA interactions were initially thought to be undruggable, recent reports of success with molecules targeting OB-fold containing proteins suggest otherwise. The potential for the development of agents targeting OB-folds is in its infancy, but if successful, would expand the opportunities to impinge on genome stability and maintenance pathways for more effective cancer treatment.
基因组稳定性和维持途径及其所需蛋白质对于遗传物质的准确复制、避免突变以及抑制包括癌症在内的人类疾病至关重要。这些蛋白质中的许多通过直接与DNA结合参与这些途径,并且有一部分利用寡核苷酸/寡糖结合折叠(OB折叠)来促进蛋白质与DNA的相互作用。OB折叠基序允许与单链DNA(ssDNA)进行序列无关的结合,并可用于将特定蛋白质定位在特定DNA结构上,然后通过蛋白质-蛋白质相互作用基序组装催化DNA复制、修复或重组的机制。本综述概述了一些与肿瘤学和药物发现最相关的含OB折叠蛋白质的OB折叠结构组织。我们讨论了它们在DNA代谢中的各自作用、针对这些基序进行药物研发的进展以及它们作为潜在癌症治疗方法的效用。虽然蛋白质与DNA的相互作用最初被认为是不可成药的,但最近针对含OB折叠蛋白质的分子取得成功的报道却并非如此。靶向OB折叠的药物开发潜力尚处于起步阶段,但如果取得成功,将扩大影响基因组稳定性和维持途径以实现更有效癌症治疗的机会。